Monetary Costs of Dementia in the United States

Abstract

BACKGROUND Dementia affects a large and growing number of older adults in the United States. The monetary costs attributable to dementia are likely to be similarly large and to continue to increase. METHODS In a subsample (856 persons) of the population in the Health and Retirement Study (HRS), a nationally representative longitudinal study of older adults, the diagnosis of dementia was determined with the use of a detailed in-home cognitive assessment that was 3 to 4 hours in duration and a review by an expert panel. We then imputed cognitive status to the full HRS sample (10,903 persons, 31,936 person-years) on the basis of measures of cognitive and functional status available for all HRS respondents, thereby identifying persons in the larger sample with a high probability of dementia. The market costs associated with care for persons with dementia were determined on the basis of self-reported out-of-pocket spending and the utilization of nursing home care; Medicare claims data were used to identify costs paid by Medicare. Hours of informal (unpaid) care were valued either as the cost of equivalent formal (paid) care or as the estimated wages forgone by informal caregivers. RESULTS The estimated prevalence of dementia among persons older than 70 years of age in the United States in 2010 was 14.7%. The yearly monetary cost per person that was attributable to dementia was either $56,290 (95% confidence interval [CI], $42,746 to $69,834) or $41,689 (95% CI, $31,017 to $52,362), depending on the method used to value informal care. These individual costs suggest that the total monetary cost of dementia in 2010 was between $157 billion and $215 billion. Medicare paid approximately $11 billion of this cost. CONCLUSIONS Dementia represents a substantial financial burden on society, one that is similar to the financial burden of heart disease and cancer. (Funded by the National Institute on Aging.)

The burden of neurological disease in theUnitedStates: A summary report and call to action

“…The total annual cost of purchased care and informal home care for each patient ranges from $45,805 to $61,525, depending on how caregiving time is calculated (eg, replacement cost vs forgone wages, care purchased in the market place and informal home care). 9 The lower annual cost estimate for AD and other dementias is $243 billion, using the most conservative per person cost of $45,805. Seventy percent of all dementias in the United States are caused primarily by AD, accounting for $170 billion of the $243 billion total cost, whereas 30% are non-AD dementias, accounting for the remaining $73 billion.…”

Saving Behavior and Portfolio Choice After Retirement

“…In particular, with regard to individuals diagnosed with degenerative diseases such as dementia, it is not unlikely that they will spend an enduring period in a nursing home; see e.g. Hurd et al (2013). In the Netherlands, roughly 30 % of the nursing home population has dementia or related disorders as reported by CIZ in 2012.…”

Apolipoproteins and HDL cholesterol do not associate with the risk of future dementia and Alzheimer’s disease: the National Finnish population study (FINRISK)

“…Dementia and Alzheimer's disease (AD) comprise a heavy health and economic burden in western countries (Mura et al 2010;Hurd et al 2013). Cardiovascular risk factors are known to predict the risk of dementia (Kivipelto et al 2006;Kaffashian et al 2013).…”